These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39414309)
1. Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey. Kotseva K; Jennings C; Bassett P; Adamska A; Hobbs R; Wood D; Open Heart; 2024 Oct; 11(2):. PubMed ID: 39414309 [TBL] [Abstract][Full Text] [Related]
2. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542 [TBL] [Abstract][Full Text] [Related]
3. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Cifkova R; Davletov K; Dilic M; Dolzhenko M; Gaita D; Gotcheva N; Hasan-Ali H; Jankowski P; Lionis C; Mancas S; Milićić D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Ž; Vulić D; Wood D; Eur J Prev Cardiol; 2021 May; 28(4):370-379. PubMed ID: 33966079 [TBL] [Abstract][Full Text] [Related]
4. ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK. Kotseva K; Jennings CS; Turner EL; Mead A; Connolly S; Jones J; Bowker TJ; Wood DA; Heart; 2012 Jun; 98(11):865-71. PubMed ID: 22581735 [TBL] [Abstract][Full Text] [Related]
5. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Castro Conde A; Cifkova R; Crowley J; Davletov K; Deckers J; De Smedt D; De Sutter J; Dilic M; Dolzhenko M; Dzerve V; Erglis A; Fras Z; Gaita D; Gotcheva N; Heuschmann P; Hasan-Ali H; Jankowski P; Lalic N; Lehto S; Lovic D; Mancas S; Mellbin L; Milicic D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Z; Stöerk S; Tokgözoğlu L; Tsioufis C; Vulic D; Wood D; Eur J Prev Cardiol; 2019 May; 26(8):824-835. PubMed ID: 30739508 [TBL] [Abstract][Full Text] [Related]
6. Primary Prevention of Cardiovascular Risk in Lithuania-Results from EUROASPIRE V Survey. Urbonas G; Vencevičienė L; Valius L; Krivickienė I; Petrauskas L; Lazarenkienė G; Karpavičienė J; Briedė G; Žučenkienė E; Vencevičius K Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32197516 [No Abstract] [Full Text] [Related]
7. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study. Ghamri RA; Alzahrani NS; Alharthi AM; Gadah HJ; Badoghaish BG; Alzahrani AA BMC Cardiovasc Disord; 2019 Nov; 19(1):268. PubMed ID: 31775642 [TBL] [Abstract][Full Text] [Related]
8. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109 [TBL] [Abstract][Full Text] [Related]
9. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Banegas JR; López-García E; Dallongeville J; Guallar E; Halcox JP; Borghi C; Massó-González EL; Jiménez FJ; Perk J; Steg PG; De Backer G; Rodríguez-Artalejo F Eur Heart J; 2011 Sep; 32(17):2143-52. PubMed ID: 21471134 [TBL] [Abstract][Full Text] [Related]
10. Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys. De Backer G; De Bacquer D; Rydén L; Kotseva K; Gaita D; Georgiev B; Gotcheva N; Mancas S; Miličić D; Pająk A; Reiner Ž; Wood D; Eur J Prev Cardiol; 2016 Oct; 23(15):1618-27. PubMed ID: 27084894 [TBL] [Abstract][Full Text] [Related]
11. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II). Boytsov S; Logunova N; Khomitskaya Y; Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151 [TBL] [Abstract][Full Text] [Related]
12. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U; Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307 [TBL] [Abstract][Full Text] [Related]
13. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648 [TBL] [Abstract][Full Text] [Related]
14. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study. Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945 [TBL] [Abstract][Full Text] [Related]
15. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy. Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091 [TBL] [Abstract][Full Text] [Related]
16. ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK. Jennings CS; Kotseva K; Bassett P; Adamska A; Wood D; Open Heart; 2020 Apr; 7(1):. PubMed ID: 32354740 [TBL] [Abstract][Full Text] [Related]
17. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices. Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552 [TBL] [Abstract][Full Text] [Related]
18. Comparison of cardiovascular disease risk factors, assessment and management in men and women, including consideration of absolute risk: a nationally representative cross-sectional study. Banks E; Welsh J; Joshy G; Martin M; Paige E; Korda RJ BMJ Open; 2020 Dec; 10(12):e038761. PubMed ID: 33371018 [TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care. Baharudin N; Ramli AS; Ramland SS; Badlie-Hisham NI; Mohamed-Yassin MS J Prim Care Community Health; 2023; 14():21501319231191017. PubMed ID: 37551146 [TBL] [Abstract][Full Text] [Related]
20. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013. Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D; Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]